AFM11 Clinical Program for Lymphoma and Leukemia on Hold Over Safety Concerns
News
Affimed has placed its AFM11 Phase 1 program on clinical hold after two life-threatening events in its lymphoma trial and one death in the leukemia study, the company announced in a press release. ... Read more